Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.

[1]  J. Fenoglio,et al.  Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. , 1987, Blood.

[2]  D. Tollefsen,et al.  Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells. , 1987, The Journal of biological chemistry.

[3]  J. Swedenborg,et al.  THROMBOGENICITY OF THE VESSEL WALL AFTER SINGLE AND REPEATED INJURY , 1987, Thrombosis and Haemostasis.

[4]  Brandt Jt,et al.  Laboratory determination of heparin cofactor II. , 1986 .

[5]  D. Farrell,et al.  Human fibroblasts accelerate the inhibition of thrombin by protease nexin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Kline,et al.  The effect of bovine thrombomodulin on the specificity of bovine thrombin. , 1986, The Journal of biological chemistry.

[7]  C. Esmon,et al.  Distribution of the thrombomodulin antigen in the rabbit vasculature. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[8]  J. Swedenborg,et al.  Uptake and Inactivation of Thrombin on Rabbit Aortic Endothelium Studied with Two Different Substrates , 1985, Thrombosis and Haemostasis.

[9]  B. Boneu,et al.  CONSTITUTIONAL HEPARIN CO-FACTOR II DEFICIENCY ASSOCIATED WITH RECURRENT THROMBOSIS , 1985, The Lancet.

[10]  G. Marbet,et al.  ASSOCIATION OF HEREDITARY HEPARIN CO-FACTOR II DEFICIENCY WITH THROMBOSIS , 1985, The Lancet.

[11]  J. Marcum,et al.  Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. , 1984, The Journal of clinical investigation.

[12]  M. Isemura,et al.  Comparison of glycosaminoglycans from thoracic aortas of several mammals. , 1984, The Tohoku journal of experimental medicine.

[13]  J. Swedenborg,et al.  Inactivation of Thrombin by the Aortic Endothelium , 1983, Thrombosis and Haemostasis.

[14]  G. White,et al.  Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma. , 1983, Blood.

[15]  K. Tanaka,et al.  Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. , 1982, Atherosclerosis.

[16]  C. Esmon,et al.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. , 1982, The Journal of biological chemistry.

[17]  S. Frebelius,et al.  Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite. , 1980, Thrombosis research.

[18]  O. Odegård,et al.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). , 1977, Thrombosis research.

[19]  R. Sykes.  Letter: Kwashiorkor and tuberculosis. , 1974, Lancet.